By the end of day’s trade on 19 May 2022, benchmark index ASX 200 dropped 1.65% and settled at 7,064.50. ASX 200 slipped after weak Wall Street performance on Wednesday. Significant drop was seen in stocks of consumer-facing companies.
Out of 11 sectors, 10 sectors settled in the red zone. Healthcare sector was the best performer during the day. On the other hand, Consumer Staples and Consumer Discretionary are the top losers with a drop of 3.61% and 2.85%, respectively.
Imugene Limited (ASX: IMU) and Aristocrat Leisure Limited (ASX: ALL) were the top gainers with an increase of 17.647% and 7.246% in their share prices respectively from its previous close. On the other hand, Nufarm Limited (ASX: NUF) were the top losers with a drop of 8.284% and 7.412% in their share prices, respectively.
Wall Street ended lower on Wednesday, driven by massive sell-off on the Wall Street with investors unnerved by fears related to inflation and possible global economic slowdown.
Rising inflation, the Ukraine conflict, prolonged supply chain challenges, and pandemic-related lockdowns in China are other factors influencing the market.
There is a buzz in the market about the probable recession by the end of 2022 and early 2023.
There has been an increase in the oil price as Russian supply squeezed by bans from several countries in wake of Ukraine invasion. Crude Oil WTI Futures are currently trading in the green zone.
The Hang Seng is down -2.45%, and the FTSE 100 is down -0.77% today.
NASDAQ-100, NASDAQ Composite, S&P 500 and Down Industrial ended lower by 5.06%, 3.20%, 4.04%, and 3.57%, respectively.
Top 5 Gainers and Losers Scoreboard:
90 Day Average Volume Outlier:
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Maven Capital Pty Ltd (AFSL No. 418504). The information contained in this article is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Suite 1A, Level 2, 802-808 Pacific Highway, Gordon NSW 2072, Australia | 1800 005 780 | info@kapitales.com.au.au
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
ASX 200 ended lower; Inflation worries grow
By the end of day’s trade on 19 May 2022, benchmark index ASX 200 dropped 1.65% and settled at 7,064.50. ASX 200 slipped after weak Wall Street performance on Wednesday. Significant drop was seen in stocks of consumer-facing companies.
Out of 11 sectors, 10 sectors settled in the red zone. Healthcare sector was the best performer during the day. On the other hand, Consumer Staples and Consumer Discretionary are the top losers with a drop of 3.61% and 2.85%, respectively.
Imugene Limited (ASX: IMU) and Aristocrat Leisure Limited (ASX: ALL) were the top gainers with an increase of 17.647% and 7.246% in their share prices respectively from its previous close. On the other hand, Nufarm Limited (ASX: NUF) were the top losers with a drop of 8.284% and 7.412% in their share prices, respectively.
Copyright © 2022 Kapitales Research
Top Performers for the day:
Top Loser for the day:
Other Factors influencing the market:
Top 5 Gainers and Losers Scoreboard:
90 Day Average Volume Outlier:
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Maven Capital Pty Ltd (AFSL No. 418504). The information contained in this article is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Suite 1A, Level 2, 802-808 Pacific Highway, Gordon NSW 2072, Australia | 1800 005 780 | info@kapitales.com.au.au